Relevance and prospects of biologic therapy in patients with systemic lupus erythematosus

Аннотация

Our research group studied the presence and amount of tumour necrosis factor in the blood, before and after treatment with monoclonal antibodies. In the course of treatment, our research team observed clinical and laboratory improvement after application of monoclonal antibodies, unlike other drugs such as steroid hormones or cytostatics